Does itaconate reduce visceral fat by inhibiting fructose 2,6-bisphosphate synthesis in rat liver?
These results indicate that itaconate, which is a decarboxylate and resembles phosphoenolpyruvate, is incorporated into liver cells and suppresses glycolysis by decreasing the level of F26BP, resulting in decreased visceral fat.
The good MRI reliability in detecting intraarticular abnormalities as demonstrated in this report, underlines its importance in the assessment of the injured knee before arthroscopy.